產(chǎn)品名稱 AT 1001
產(chǎn)品貨號 Axon 2401 CAS [1314801-63-2] MF C15H21BrN2MW 309.24 Purity: 100% Optical purity: Relative stereochemistry Soluble in 0.1N HCl(aq) and DMSO Description High affinity and selective α3β4 nAChR ligand (Ki value 2.6?nM at α3β4 nAChR) with both partial agonistic and antagonistic effects, and >90-fold selective over the other major subtypes, the α4β2 and α7 nAChR. AT-1001 potently and dose-dependently blocks nicotine self-administration in rats, without affecting food responding, and shows a mechanism of action very different from varenicline (Axon 1384 (HCl salt) and Axon 2074 (tartrate salt)). References Certificates Categories Extra info A. Cippitelli et al. AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology. Br J Pharmacol. 2015 Apr;172(7):1834-45. ? L. Toll et al. AT-1001: a high affinity and selective α3β4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats. Neuropsychopharmacology. 2012 May;37(6):1367-76. ? E.W. Tuan et al. AT-1001 is a Partial Agonist with High Affinity and Selectivity at Human and Rat α3β4 Nicotinic Cholinergic Receptors. Mol Pharmacol. 2015 Jul 10. pii: mol.115.099978. [Epub ahead of print] Certificate of Analysis Material Safety Data Sheet CNS Pain & Inflammation nAChR Unclassified High affinity and selective α3β4 nAChR ligand with partial agonistic and antagonistic effects Chemical name N-(2-bromophenyl)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine Parent CAS No. [1314801-63-2] Order Size Unit Price Stock 10 mg €95.00 In Stock
產(chǎn)品價格 現(xiàn)貨詢價,電話:010-67529703
產(chǎn)品規(guī)格
產(chǎn)品品牌 axonmedchem
產(chǎn)品概述
產(chǎn)品詳情

AT 1001

Based on 16 reference(s) in Google Scholar 9 10 16

Axon 2401

CAS [1314801-63-2]

MF C15H21BrN2
MW 309.24

  • Purity: 100%
  • Optical purity: Relative stereochemistry
  • Soluble in 0.1N HCl(aq) and DMSO

AT 1001

Description

High affinity and selective α3β4 nAChR ligand (Ki value 2.6?nM at α3β4 nAChR) with both partial agonistic and antagonistic effects, and >90-fold selective over the other major subtypes, the α4β2 and α7 nAChR. AT-1001 potently and dose-dependently blocks nicotine self-administration in rats, without affecting food responding, and shows a mechanism of action very different from varenicline (Axon 1384 (HCl salt) and Axon 2074 (tartrate salt)).

產(chǎn)品資料